Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Abbreviated MRI could become standard of care for prostate cancer diagnosis
Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly.
Late-stage prostate cancer diagnoses on the rise
Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers.
Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer
When used during surgery, it can help providers identify cancerous lesions that are not in their immediate vision.
Shine working toward U.S. production of Mo-99 for SPECT imaging
Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.
New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care
The method targets cancer stem cells, which are highly tumorigenic and known to play a significant role in relapse, cancer spread and treatment resistance.

Breast MRI screening cuts cancer mortality rates in half for women with lesser-known gene mutations

Women with ATM, CHEK2 and PALB2 gene mutations would benefit from beginning MRI screenings earlier than previously recommended, experts reported in JAMA Oncology.

MRI-guided radiotherapy for prostate cancer cuts treatment side effects in half

The team originally planned to enroll 300 men in the study, but the decisive results seen among the first 100 patients prompted them to cut enrollment in half.

Significant uptick of late-stage cancer diagnoses attributed to COVID

Concerningly, the number of patients diagnosed with stage 4 disease increased from 1.9% in 2019 to 6.2% in 2020, experts reported in JAMA Network Open.

Combining neural network with breast density measurements boosts interval cancer detection rates

With up to 30% of breast cancers developing in between screenings, there is a great need to improve risk assessments, experts discussed recently in Radiology.

MR-guided thermoseeds can destroy cancerous brain tissue

"Improving the precision of treatment delivery is arguably the greatest unmet need we have in contemporary medicine," experts explained in Advanced Science.

Machine learning model accurately predicts DCIS upstaging without invasive surgery

Understanding a patient's risk of developing invasive cancer without having to undergo surgery could help patients and providers choose more appropriate treatment plans.

RSNA21: Two-thirds of states did not prioritize vulnerable cancer patients during initial COVID vaccine rollout

Regulators must ensure that vulnerable populations receive their booster shots in a timely fashion.

While promising, machine learning still misses 20% of cancers on breast MRIs, analysis shows

AI proved useful for detecting axillary lymph node metastases but isn’t yet ready for clinics, experts said recently.

Oncology Imaging

Abbreviated MRI could become standard of care for prostate cancer diagnosis

Late-stage prostate cancer diagnoses on the rise

Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer

Shine working toward U.S. production of Mo-99 for SPECT imaging

New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care